HEOR & Health Economics Consulting Services

We provide professional HEOR consulting and health economics consulting services for life sciences, healthcare organizations, and public agencies that need rigorous cost-effectiveness analysis services, real-world evidence, and outcomes research.

Health Economics Cost-Effectiveness Analysis Real-World Evidence HTA & Value Payer & Policy Analytics
Request HEOR & Health Economics Consulting
Need defensible economic evidence to support pricing, reimbursement, or policy decisions?
Our HEOR and health economics consulting services help organizations quantify value, evaluate trade-offs, and produce decision-grade cost-effectiveness and outcomes analyses.

Comprehensive HEOR & Health Economics Expertise

We combine advanced academic training in Health Economics & Outcomes Research with deep practical experience in real-world data analytics, epidemiology, and clinical outcomes research.

Our HEOR consulting services support value assessment, comparative effectiveness, reimbursement strategy, and policy-relevant evidence development—aligned with ISPOR good practices and global HTA expectations.

Economic Value

Cost-Effectiveness Analysis Services

Cost-effectiveness analysis, decision-analytic and Markov modeling, budget impact analysis, and probabilistic uncertainty modeling to support HTA and payer evaluation.

Observational Data

Real-World Evidence (RWE)

Claims, EMR, registry, and cohort analyses using PSM, IPTW, regression, longitudinal, and survival methods to assess effectiveness and safety.

Clinical Evidence

Clinical Outcomes Research

Comparative effectiveness research, survival analysis, patient-reported outcomes, treatment pathways, and epidemiologic study design.

Market Access

HTA & Value Communication

HTA-aligned models and evidence packages, AMCP dossiers, value narratives, and payer-facing analytics supporting reimbursement decisions.

Literature Review

Evidence Synthesis

Systematic and targeted literature reviews, evidence maps, and meta-analyses supporting RWE, HEOR, and HTA strategies.

Advanced Modeling

Advanced Analytics & Modeling

Predictive modeling, risk stratification, time-to-event analysis, and advanced analytics using R, Python, and scientific platforms.

Selected HEOR Case Studies

Our HEOR consulting portfolio includes collaborations with federal agencies, academic institutions, and major clinical organizations.

Selected HEOR Case Studies

Our HEOR portfolio includes collaborations with federal agencies, academic institutions, and clinical organizations.

CDC — Cost-Effectiveness of HPV Vaccination

National-scale epidemiologic and economic modeling to inform vaccination policy.

FDA — Smoking-Cessation Economic Evaluation

Multi-state modeling of clinical and financial impacts for regulatory decision-making.

Mayo Clinic — Real-World Impact of Gene Expression Profiling

Linked SEER-Medicare analysis supporting personalized oncology care.

Duke University — Surgical Outcomes Research

Large-scale outcomes and utilization studies across reconstructive procedures.

Tufts University — Comparative Effectiveness in Dermatology

Observational analytics supporting therapeutic decision-making.

Publications & Academic Rigor

While HEOR client engagements are confidential, our expertise is reflected in a strong record of peer-reviewed publications across outcomes research, epidemiology, and health services.

  1. Critical analysis of pemphigus vulgaris in pregnancy
  2. Active shooters and gun-free zones: emotional versus legal motivations
  3. Evaluating Disparities in Pathways to Breast Reconstruction
  4. Metabolic Derangement and Wound Complications in Elective Plastic Surgery
  5. Predicting Academic Performance in Plastic Surgery Residency
  6. Prophylactic Post-Operative Antibiotics in Tissue Expander-Based Reconstruction
  7. Tissue Expander Fill and Complications: A Propensity-Matched Analysis
  8. Defining the Value of Breast Reconstruction Surgeons
  9. Health Plan Enrollment and Mortality in Medicare
  10. Enhancing SmokefreeTXT: User-Reported Data Evaluation
  11. Complications and Utilization in Aesthetic Surgery
  12. Mapping Breast Cancer Care Encounters
  13. Age and Complications in Congenital Breast Deformity Correction
  14. Air vs. Saline: A Propensity-Matched Analysis
  15. Predictors of Academic Productivity in Plastic Surgery
Contact